Physician profile
Ajit J Deshmukh
NPI 1790002020
$7,174.86
in general payments reported to CMS, 2019-2025
14 companies · $4,609 in 2025
The $4,609 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $113 · 2021: $299 · 2022: $1,339 · 2023: $488 · 2024: $56.06 · 2025: $4,609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,000 · Travel and Lodging: $815 · Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,000.00 |
| Travel and Lodging | $814.85 |
| Food and Beverage | $338.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intellijoint Surgical INC. | $4,000.00 | 2025 | Intellijoint Hip |
| Smith+Nephew, INC. | $1,224.80 | 2020-2022 | |
| Stryker Corporation | $892.99 | 2023-2025 | Mako |
| Linkbio Corp | $298.72 | 2021 | |
| Exactech, INC. | $212.56 | 2022-2023 | |
| Ermi LLC | $159.94 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $125.80 | 2025 | Persona |
| Microport Orthopedics INC | $103.51 | 2019 | |
| Orthofix Medical, INC. | $47.76 | 2019 | |
| Solventum Corporation | $36.42 | 2024 | Activ.A.C. |
| Bioventus LLC | $21.37 | 2019 | |
| Opko Pharmaceuticals, LLC | $19.64 | 2024 | Rayaldee |
| Horizon Therapeutics Plc | $16.13 | 2020 | |
| Globus Medical, INC. | $15.22 | 2025 | Stelkast Generic Knee Instruments, Stelkast Generic Hip Instruments |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajit Deshmukh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.